Snowden Capital Advisors’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
12,129
-99
-0.8% -$9.31K 0.03% 509
2026
Q1
$1.14M Buy
12,228
+426
+4% +$41.7K 0.03% 490
2025
Q4
$1.15M Buy
11,802
+75
+0.6% +$7.1K 0.03% 486
2025
Q3
$1.04M Sell
11,727
-3,335
-22% -$288K 0.03% 514
2025
Q2
$1.3M Sell
15,062
-507
-3% -$43.6K 0.04% 439
2025
Q1
$1.42M Buy
15,569
+860
+6% +$78.1K 0.05% 393
2024
Q4
$1.26M Sell
14,709
-468
-3% -$43.2K 0.04% 429
2024
Q3
$1.49M Sell
15,177
-388
-2% -$37.6K 0.04% 405
2024
Q2
$1.45M Sell
15,565
-151
-1% -$13.8K 0.04% 406
2024
Q1
$1.46M Buy
+15,716
New +$1.42M 0.05% 403
2022
Q1
Sell
-610
Closed -$55K 1556
2021
Q4
$55K Buy
+610
New +$52.7K ﹤0.01% 1006

Other funds holding IXJ

Snowden Capital Advisors's IXJ Position: Q2 2026 in Review

Snowden Capital Advisors reduced its iShares Global Healthcare ETF (IXJ) stake by 0.81% in Q2 2026, selling an estimated $9.31K and leaving 12,129 shares worth $1.19M. The position accounts for 0.03% of the portfolio, ranked #509.

Snowden Capital Advisors first reported a position in IXJ in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.49M in Q3 2024. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Snowden Capital Advisors held 12,129 shares of iShares Global Healthcare ETF worth $1.19M as of Q2 2026.
  • Snowden Capital Advisors sold 99 iShares Global Healthcare ETF shares in Q2 2026, an estimated $9.31K.
  • iShares Global Healthcare ETF made up 0.03% of Snowden Capital Advisors's portfolio in Q2 2026, its #509 holding.
  • Snowden Capital Advisors first reported a position in iShares Global Healthcare ETF in Q4 2021 and has held it in 11 quarters since.
  • Snowden Capital Advisors's iShares Global Healthcare ETF position peaked at $1.49M in Q3 2024.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.